Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Revenue

In the year 2025, Lyra Therapeutics had annual revenue of $398.00K, down -74.05%. Lyra Therapeutics had revenue of $7.00K in the quarter ending December 31, 2025, a decrease of -96.65%.

• Revenue: 398.00K
• Revenue Growth: -74.05%
• P/S Ratio: 1.25
• Revenue / Employee: 14.74K
• Employees: 27
• Market Cap: 496.97K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	398.00K	-1.14M	-74.05%
Dec 31, 2024	1.53M	-24.00K	-1.54%
Dec 31, 2023	1.56M	195.00K	14.31%
Dec 31, 2022	1.36M	1.08M	378.25%
Dec 31, 2021	285.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error